Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: A role for brain-derived neurotrophic factor

Acta Pharmacologica Sinica

Volumn 33, Issue 1, 2012, Pages 5-10

  Xie, Hui ^a   Yung, Wing Ho ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

brain derived neurotrophic factor; intermittent hypoxia; long term potentiation; obstructive sleep apnea; synaptic plasticity

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; REACTIVE OXYGEN METABOLITE; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; SODIUM CHANNEL; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR;

APOPTOSIS; BRAIN FUNCTION; BREATHING DISORDER; CHRONIC INTERMITTENT HYPOXIA; COGNITION; DISEASE ASSOCIATION; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HYPOXIA; LONG TERM POTENTIATION; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIGNAL TRANSDUCTION; SLEEP; SLEEP APNEA SYNDROME; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ANIMALS; ANOXIA; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DISEASE MODELS, ANIMAL; HUMANS; NEURONAL PLASTICITY; OXIDATIVE STRESS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84855422748     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.184     Document Type: Review

References (63)

1. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern med 2005; 142: 187-97. (Pubitemid 40189111)
2. Mathieu A, Mazza S, De'cary A, Massicotte-Marquez J, Petit D, Gosselin N, et al. Effects of obstructive sleep apnea on cognitive function: A comparison between younger and older OSAS patient. Sleep Med 2007; 9: 112-20.
3. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnea. Eur Respir J 1995; 8: 1161-78.
4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Eng J Med 1993; 328: 1230-5. (Pubitemid 23115702)
5. Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovas Dis 2009; 4: 303-12.
6. Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-60.
7. Hoffman B, Wingenbach D, Kagey AN, Schaneman JL, Kasper D. The long-term health plan and disability cost beneft of obstructive sleep apnea treatment in a commercial motor vehicle driver population. J Occup Environ Med 2010; 52: 473-7.
8. Ali NJ, Pitson D, Stradling JR. Sleep disordered breathing: effects of adenotonsillectomy on behaviour and psychological functioning. Eur J Pediatr 1996; 155: 56-62. (Pubitemid 26005506)
9. Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997; 20: 1185-92. (Pubitemid 28082313)
10. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102: 616-20. (Pubitemid 28409262)
11. Gozal D, Daniel JM, Dohanich GP. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 2001; 21: 2442-50. (Pubitemid 32240541)
12. Gozal D. Effects of intermittent hypoxia on neurological function. In Brain Hypoxia and Ischemia 2009; (Eds Haddad GG, Yu SP). Humana Press.
13. Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002; 52: 449-53. (Pubitemid 34920280)
14. Tsai JC. Neurological and neurobehavioral sequelae of obstructive sleep apnea. NeuroRehabilitation 2010; 26: 85-94.
15. Jackson ML, Howard ME, Barnes M. Cognition and daytime func tion-ing in sleep-related breathing disorders. Prog Brain Res 2011; 190: 53-68.
16. Goldbart A, Row BW, Kheirandish L, Schurr A, Gozal E, Guo SZ, et al. Intermittent hypoxic exposure during light phase induces changes in cAMP response element binding protein activity in the rat CA1 hippocampal region: Water maze performance correlates. Neuroscience 2003; 122: 583-90.
17. Goldbart A, Cheng ZJ, Brittia KR, Gozal D. Intermittent hypoxia induces time-dependent changes in the protein kinase B signaling pathway in the hippocampal CA1 region of the rat. Neurobiol Dis 2003; 14: 440-6. (Pubitemid 37543522)
18. Gozal D, Row BW, Gozal E, Kheirandish K, Neville JJ, Brittian KR, et al. Temporal aspects of spatial task performance during intermittent hypoxia in the rat: evidence for neuro genesis. Eur J Neurosci 2003; 18: 2335-42. (Pubitemid 38117407)
19. Kheirandish K, Gozal D, Pequignot JM, Pequignot J, Row BW. Intermittent hypoxia during development induces long-term alteration in spatial working memory, monoamines, and dendritic branching in rat frontal cortex. Pediatr Res 2005; 58: 594-9. (Pubitemid 41254530)
20. Kheirandish K, Row BW, Li RC, Brittian KR, Gozal D. Apolipoprotein E-defcient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning defcits. Sleep 2005; 28: 1412-7. (Pubitemid 41572792)
21. Tartar JL, Ward CP, McKenna JT, Thakkar M, Arrigoni E, McCarley RW, et al. Hippocampal synaptic plasticity and spatial learning are impaired in a rat model of sleep fragmentation. Eur J Neurosci 2006; 23: 2739-48. (Pubitemid 43801466)
22. Ward CP, McCoy JG, McKenna JT, Connolly NP, McCarley RW, Strecker RE. Spatial learning and memory deficits following exposure to 24 h of sleep fragmentation or intermittent hypoxia in a rat model of obstructive sleep apnea. Brain Res 2009; 1294: 128-37.
23. Payne RS, Goldbart A, Gozal D, Schurr A. Effect of intermittent hypoxia on long-term potentiation in rat hippocampal slices. Brain Res 2004; 1029: 195-9. (Pubitemid 39470175)
24. Gu XQ, Haddad GG. Maturation of neuronal excitability in hippocampal neurons of mice chronically exposed to cyclic hypoxia. Am J Physiol Cell Physiol 2003; 284: C1156-63. (Pubitemid 36457396)
25. + Channel expression in developing mouse brain. Int J Dev Neurosci 2005; 23: 327-33. (Pubitemid 40779449)
26. Xie H, Leung KL, Chen L, Chan YS, Cheung PK, Fok TF, et al. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippo campal long-term synaptic plasticity. Neurobiol Dis 2010; 40: 155-62.
27. Wang Y, Zhang SXL, Gozal D. Reactive oxygen species and the brain in sleep apnea. Respir Physio Neurobiol 2010; 174: 307-16.
28. Row BW, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning defcits in the rat. Am J Respir Crit Care Med 2003; 167: 1548-53. (Pubitemid 37363366)
29. Zhan G, Fenik P, Pratico D, Veasey SC. Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and bran injury. Am J Respir Crit Care Med 2005; 171: 1414-20. (Pubitemid 40800515)
30. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 2004; 126: 313-23. (Pubitemid 38780807)
31. Hui-guo L, Kui L, Yan-ning Z, Yong-jian X. Apocynin attenuate spatial learning efcits and oxidative responses to intermittent hypoxia. Sleep Med 2010; 11: 205-12.
32. Nair D, Dayyat EA, Zhang SX, Wang Y, Gozal D. Intermittent hypoxia-induced cognitive defcits are mediated by NADPH oxidase activity in a murine model of sleep apnea. PLoS One 2011; 6: e19847.
33. Fung SL, Xi MC, Zhang JH, Sampogna S, Yamuy J, Morales FR, et al. Apnea promotes glutamate-induced excitotoxicity in hippocampal neurons. Brain Res 2007; 1179: 42-50. (Pubitemid 47633508)
34. Li RC, Row BW, Kheirandish L, Brittian KR, Gozal E, Guo SZ, et al. Nitric oxide synthase and intermittent hypoxia-induced spatial learning defcits in the rat. Neurobiol Dis 2004; 17: 44-53. (Pubitemid 39209311)
35. Ryan S, McNicholas WT, Taylor C. A critical role for p38 map kinase in NF-kB signaling during intermittent hypoxia/reoxygenation. Biochem Bio phys Res Com 2007; 355: 728-33. (Pubitemid 46330212)
36. Li RC, Row BW, Gozal E, Kheirandish L, Fan Q, Brittian KR, et al. Cyclo oxygenase 2 and intermittent hypoxia-induced spatial defcits in the rat. Am J Respir Crit Care Med 2003; 15: 469-75. (Pubitemid 37046877)
37. Thoenen H. The changing scene of neurotrophic factors. Trends Neuro sci 1991; 14: 165-70.
38. Lewin GR, Barde YA. Physiology of the neurotrophins. Ann Rev Neuro-sci 1996; 19: 289-317. (Pubitemid 26080831)
39. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000; 14: 2919-37.
40. Poo MM. Neurotrophin as synaptic modulators Nat. Rev Neurosci 2001; 2: 24-32.
41. Lu B. Acute and long-term synaptic modulation by neurotrophins. Prog Brain Res 2004; 146: 137-50. (Pubitemid 37541381)
42. Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A. From modulator to mediator: rapid effects of BDNF on ion channels. Bio-essays 2004; 26: 1185-94. (Pubitemid 39536614)
43. Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 2008; 89: 312-23. (Pubitemid 351318269)
44. Pang P, Teng H, Zaitsev E, Woo NT, Sakata K, Zhen S, et al. Proteolytic conversion from pro-to mature BDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004; 305: 487-91. (Pubitemid 39372449)
45. Egan M, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-69. (Pubitemid 36144114)
46. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-102. (Pubitemid 39492034)
47. Chiaretti A, Pastra M, Polidori G, Di Rocco C, Caresta E, Antonell A, et al. Correlation between neurotrophic factor expres sion and outcome of children with severe traumatic brain injury. Intensive Care Med 2003; 29: 1329-38. (Pubitemid 37045379)
48. Chiaretti A, Antonelli A, Piastra M, Genovese O, Polidori G, Aloe L. Expression of neurotrophic factors in cerebrospinal fuid and plasma of children with viral and bacterial meningoencephalitis. Acta Paediatr 2004; 93: 1178-84. (Pubitemid 39099716)
49. Dale-Nagle EA, Hoffman MS, MacFarlane PM, Satriotomo I, Lovett-Barr MR, Vinit S, et al. Spinal plasticity following intermittent hypoxia: implications for spinal injury. Ann N Y Acad Sci 2010; 1198: 252-9.
50. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, et al. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain region. Sleep 2004; 27: 194-201. (Pubitemid 44138826)
51. Polotsky VY, Rubin AE, Balbir A, Dean T, Smith PL, Schwartz AR, et al. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med 2006; 7: 7-16. (Pubitemid 43033539)
52. Zhu XH, Yan HC, Zhang J, Qu HD, Qiu XS, Chen L, et al. Intermittent hypoxia promotes hippocampal neurogenesis and produces anti-depressant-like effects in adult rats. J Neurosci 2010; 30: 12653-63.
53. Wilkerson JE, Mitchell GS. Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitation. Exp Neurol 2009; 217: 116-23.
54. Numakawa T, Matsumoto T, Numakawa Y, Ricahrds M, Yamawaki S, Kunugi H. Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J Toxicol 2011; 2011: 405194.
55. Boutahar N, Reynaud E, Lassabliere F, Borg J. Brain-derived neuro-trophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress. J Neurosci Res 2010; 8: 2263-71.
56. Thomas RJ, Rosen BR, Stern CE, Weiss W, Wong KK. Functional imaging of working memory in obstructive sleep-disordered nreathing. J Appl Physiol 2005; 98: 2226-34. (Pubitemid 40726919)
57. Tartar JL, McKenna JT, Ward CP, McCarley RW, Strecker RE, Brown RE. Sleep fragmentation reduces hippocampal CA1 pyramidal cell excitability and response to adenopsine. Neurosci Lett 2010; 469: 1-5.
58. Simmons DA, Rex CS, Palmer L, Pandyaranjan V, Fedulov V, Gall CM, et al. Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 2009; 106: 4906-11.
59. Arai AC, Kessler M. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets 2007; 8: 583-602. (Pubitemid 46785059)
60. Nagarajan N, Quast C, Boxall AR, Shahid M, Rosenmund C. Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546. Neuropharmacology 2001; 41: 650-63. (Pubitemid 32972182)
61. Kramar EA, Chen LY, Lauterborn JC, Simmons DA, Gall CM, Lynch G. BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats. Neurobiol Aging 2010. doi:10.1016/j.neurobiolaging.2010.06.008
62. Lynch G. Memory enhancement: the search for mechanism-based drugs. Nat Neurosci 2002; 5: 1035-8. (Pubitemid 35247193)
63. Wezenberg E, Verkes RJ, Ruigt GS, Hulstjin W, Sabbe BG. Acute effects of ampakine farampator on memory and information processing in healthy elderly volunteers. Neuropsychopharmacol 2007; 32: 1272-83. (Pubitemid 46788860)